|
🐢
|
Molecular regulation of angiogenesis and lymphangiogenesis
R. Adams,
K. Alitalo
|
10 |
2007 |
10
🐢
|
|
🐜
|
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
10 auth.
M. Skobe,
T. Hawighorst,
D. Jackson,
R. Prevo,
L. Janes,
P. Velasco,
...
L. Riccardi,
K. Alitalo,
K. Claffey,
M. Detmar
|
10 |
2001 |
10
🐜
|
|
🐢
|
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
8 auth.
Aleksanteri Aspelund,
Salli Antila,
Steven T. Proulx,
T. Karlsen,
Sinem Karaman,
M. Detmar,
...
H. Wiig,
K. Alitalo
|
10 |
2015 |
10
🐢
|
|
🐢
|
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.
8 auth.
A. Kaipainen,
J. Korhonen,
T. Mustonen,
V. Hinsbergh,
G. Fang,
D. Dumont,
...
M. Breitman,
K. Alitalo
|
10 |
1995 |
10
🐢
|
|
🐢
|
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins
12 auth.
M. Karkkainen,
P. Haiko,
K. Sainio,
J. Partanen,
J. Taipale,
T. Petrova,
...
M. Jeltsch,
D. Jackson,
M. Talikka,
H. Rauvala,
C. Betsholtz,
K. Alitalo
|
10 |
2004 |
10
🐢
|
|
🐜
|
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour
9 auth.
M. Schwab,
K. Alitalo,
K. Klempnauer,
H. Varmus,
J. Bishop,
F. Gilbert,
...
G. Brodeur,
M. Goldstein,
J. Trent
|
10 |
1983 |
10
🐜
|
|
🐢
|
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
H. Augustin,
G. Koh,
G. Thurston,
K. Alitalo
|
10 |
2009 |
10
🐢
|
|
🐢
|
Lymphangiogenesis: Molecular Mechanisms and Future Promise
T. Tammela,
K. Alitalo
|
10 |
2010 |
10
🐢
|
|
🐢
|
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.
10 auth.
M. Jeltsch,
A. Kaipainen,
V. Joukov,
Xiaojuan Meng,
M. Lakso,
H. Rauvala,
...
M. Swartz,
D. Fukumura,
R. Jain,
K. Alitalo
|
10 |
1997 |
10
🐢
|
|
🦁
|
Lymphangiogenesis in development and human disease
K. Alitalo,
T. Tammela,
T. Petrova
|
10 |
2005 |
10
🦁
|
|
🐜
|
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
8 auth.
M. G. Achen,
M. Jeltsch,
E. Kukk,
T. Makinen,
A. Vitali,
A. Wilks,
...
K. Alitalo,
S. Stacker
|
10 |
1998 |
10
🐜
|
|
🐢
|
A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases.
9 auth.
V. Joukov,
K. Pajusola,
A. Kaipainen,
D. Chilov,
I. Lahtinen,
E. Kukk,
...
O. Saksela,
N. Kalkkinen,
K. Alitalo
|
10 |
1996 |
10
🐢
|
|
🐜
|
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
11 auth.
S. Breiteneder-Geleff,
A. Soleiman,
H. Kowalski,
R. Horvat,
G. Amann,
E. Kriehuber,
...
Katja Diem,
W. Weninger,
E. Tschachler,
K. Alitalo,
D. Kerjaschki
|
10 |
1999 |
10
🐜
|
|
🐢
|
Clinical applications of angiogenic growth factors and their inhibitors
N. Ferrara,
K. Alitalo
|
10 |
1999 |
10
🐢
|
